Investigating heart disease risk factors in psoriasis patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the relationship between cardiac biomarkers and advanced echocardiography in patients with psoriasis. By enrolling a cohort of 1,000 participants, the researchers will assess whether these biomarkers can serve as prognostic indicators for cardiovascular disease. The study focuses on the shared inflammatory pathways between psoriasis and cardiovascular conditions, examining how these factors contribute to heart disease risk. The findings may enhance understanding of cardiovascular health in individuals suffering from psoriasis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients 18 years or older with a diagnosis of psoriasis will be invited to participate

Exclusion Criteria:

* Patients not able to cooperate to the study
* Patients unable understand and sign informed consent

Where it's running

• Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen
  Hellerup, Copenhagne, Denmark Recruiting

Study contacts

• Study coordinator: Maria F Dons, MD
• Email: mariaflarupdons@hotmail.com
• Phone: +4560604780

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using a smartphone device to record 12-lead ECGs for heart attack diagnosis

  This study is testing a smartphone device that records heart activity to see if it can help doctors quickly diagnose heart attacks in adults who come to the emergency room with chest pain.

  Recruiting at 2 sites AliveCor · Rochester, Minnesota and 3 other locations · NCT06271577

• Comparing Aortix Device to Diuretics for Acute Heart Failure

  This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.

  Recruiting at 33 sites Procyrion · Phoenix, Arizona and 49 other locations · NCT05677100

• LY3971297 in heart failure: safety and tolerability in HF with preserved and reduced ejection fraction

  This study tests how well LY3971297 is tolerated and what side effects occur in people with HFpEF or HFrEF.

  Recruiting Phase 1 Eli Lilly and Company · Detroit, Michigan and 11 other locations · NCT07547540

• Coronary CT angiography–guided calcium modification during PCI for calcified coronary artery disease

  This study will see if using CT angiography to plan calcium treatment before stenting helps people with flow-limiting, calcified coronary artery disease have better stent results and faster procedures compared with the usual ultrasound-guided PCI while keeping similar safety.

  Recruiting at 10 sites Fundación EPIC · Boston, Massachusetts and 14 other locations · NCT07286578

• Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions

  This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.

  Recruiting at 3 sites Teleflex · Washington D.C., District of Columbia and 2 other locations · NCT07258290

• Cardiovascular risk in people with Crohn's disease and ulcerative colitis

  This study tests whether people with inflammatory bowel disease have different heart-attack or stroke risk over two years compared with matched controls.

  Recruiting IRCCS Policlinico S. Donato · San Donato Milanese, Milan · NCT07095634

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.